Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats
- 1 September 1988
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 95 (1) , 197-208
- https://doi.org/10.1111/j.1476-5381.1988.tb16565.x
Abstract
The regional haemodynamic effects of i.v. bolus doses of atrial natriuretic peptide (ANP, 1 and 10 nmol), calcitonin gene-related peptide (CGRP, 0.05 and 0.5 nmol) and corticotropin-releasing factor (CRF, 1 and 5 nmol) were assessed in conscious Long Evans and Brattleboro rats chronically instrumented with miniaturized, pulsed Doppler probes. The low dose of ANP was without effect on mean arterial pressure (MAP), but caused tachycardia and hindquarters vasodilatation with vasoconstriction in renal and mesenteric beds in Long Evans rats. Wigh the high doses of ANP these effects were more pronounced and MAP fell. In Brattleboro rats there was a primary renal vasodilatation. The low dose of CGRP caused a slight fall in MAP in Long Evans rats, tachycardia and a renal vasodilatation. The high dose of CGRP caused marked hypotension, tachycardia and renal mesenteric and hindquarters vasodilatation in both strains of rat. However, only in Long Evans rats were there secondary renal and mesenteric vasoconstrictions. The low dose of CRF caused falls in MAP in both strains of rat, accompanied by renal and, particularly, mesenteric vasodilatation. Administration of the high dose of CRF caused profound, prolonged hypotension, tachycardia and mesenteric vasodilatation. There was also (late onset) hindquarters vasodilatation accompanying renal vasoconstriction that followed the initial vasodilatation in this vascular bed. These results indicate that appropriate doses of particular peptides may be capable of promoting flow through individual peripheral vascular beds.This publication has 30 references indexed in Scilit:
- Regulation of Guanylate Cyclase by Atrial Natriuretic Factor and the Role of Cyclic GMP in VasodilationThe Lancet Healthy Longevity, 1987
- Regional vasodilator actions of calcitonin gene-related peptide in conscious SHRPeptides, 1987
- Systemic and regional hemodynamic effects of calcitonin gene-related peptide.Hypertension, 1987
- Vascular amplifier properties in renovascular hypertension in conscious rabbits. Hindquarter responses to constrictor and dilator stimuli.Hypertension, 1987
- Hemodynamic effects of infusion versus bolus administration of atrial natriuretic factor.Hypertension, 1986
- Possible mechanisms of positive inotropic action of synthetic human calcitonin gene-related peptide in isolated rat atriumPeptides, 1986
- Lack of renal vasodilation during intrarenal infusion of synthetic atriopeptin II in conscious intact SHRLife Sciences, 1986
- Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.Hypertension, 1984
- The Renin Angiotensin System in Conscious Brattleboro Strain RatsKidney and Blood Pressure Research, 1982